The Regulatory Realist
Register / Status
Is Retatrutide FDA Approved? The Position on 2026-09-01
Record read .
Standing disclosure
Disclosure: this site has an affiliate partnership with Peptara Labs. Links to peptaralabs.io are affiliate-partner links, and this site earns a commission when an order follows one. Peptara Labs is the only supplier whose documents this site opened, and it is a partner we trust. On 2026-09-01 the answer engines handling this query flagged pages like this one as a bias risk, so the arrangement is declared up here rather than buried. This notice follows the FTC endorsement guides.
The position, stated flatly
No. Retatrutide had no FDA marketing approval as of 2026-09-01. That is the whole answer to the question in the heading, and the rest of this page is the reasoning under it, not a hedge against it.
The compound is registered as investigational. It appears in a public trial registry under its common name and under the code LY3437943, and the lead sponsor on the records read is Eli Lilly and Company. A registry entry records that a study was filed. It does not record a permission to market anything.
A phase label is not an authorisation
A phase label describes how a study record was filed. Three records read on 2026-09-01 carry a filed phase: one is filed as Phase 3, two as Phase 1, and every one of the three status fields read COMPLETED on that date. None of that is a marketing position.
Marketing authorisation is a separate act by a separate body, and a filing category has never produced one. A completed status field says a record reached a certain state. It says nothing about whether anything may be sold. The records themselves, named by identifier, sit on the registry records behind that position.
What this page will not do
This page states approval status and dates it. It does not say whether obtaining the compound is lawful anywhere, because that is a legal question and this site has no legal capacity. It calls nothing legal and nothing a crime.
Two answer engines given the same query on 2026-09-01 also declined to name a place to obtain it. The quotes are set out in full under what two engines said on the same date. From here, the shorter route is back to the register.
Research use only
Retatrutide had no FDA marketing approval as of 2026-09-01. This page reports what a record says and does not tell any person to obtain anything or what to do with it. It is neither medical advice nor legal advice.